11/11/2026
Jardiance (empagliflozin) is an SGLT2 inhibitor originally developed for type 2 diabetes, but it’s gaining attention in the longevity and performance enhancement space.
It works by preventing your kidneys from reabsorbing some glucose, allowing you to excrete it through urine.
The result? Lower blood sugar, increased calorie loss, and potentially modest improvements in body composition.
But things get interesting beyond fat loss.
Jardiance has demonstrated significant cardiovascular and kidney benefits in certain populations, making it an interesting candidate for longevity research.
However, it can also increase hematocrit through increased red blood cell production, something enhanced athletes should pay particular attention to.
Understanding what’s happening UNDER THE HOOD matters!
For more deep dives into peptides, small molecules, longevity, and performance enhancement, join the DDT Method SKOOL group!
Comment SKOOL for access!
Disclaimer: Educational purposes only. Not medical advice. Jardiance is a prescription medication with potential risks, and longevity benefits in healthy individuals remain unproven.